Back

The effects of STAtin-FENOfibrate combination therapy vs. statin monotherapy on necrotic core and plaque characteristics in non-diabetic patients with combined dyslipidemia and intermediate CAOD

30 August 2026 (17:15 - 17:45)
Organised by: Logo
Congress Presentation Part of: Innovative therapeutic strategies in coronary artery disease Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Seung Hwan Han

Gachon University Gil Medical Center, Incheon (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Spinal Cord Stimulation in patients with Refractory Angina Pectoris (SCRAP); double-blind, placebo-controlled, cross-over randomized controlled trial
Miss F. Vervaat (Eindhoven, NL)
Abstract
Presentation thumbnail
Long-term adherence to secondary preventive medications after myocardial infarction: a post-hoc analysis of the BETAMI trial
Ms A. Bakken (Oslo, NO)
Abstract
Presentation thumbnail
Safety and efficacy of coronary sinus narrowing for treating refractory angina in real-world setting - single center experience
Ms J. Grygier (Poznan, PL)
Abstract
Presentation thumbnail
Natriuretic peptides reverse vascular insulin resistance and supress insulin-induced mechanisms of atherogenesis
Doctor D. Foran (Oxford, GB)
Abstract

Access the full session

Session thumbnail
Innovative therapeutic strategies in coronary artery disease

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol and its role in patients with coronary atherosclerosis evaluated by coronary CT
13 December 2025
thumbnail
Congress Presentation
Statin therapy in chronic heart failure with reduced ejection fraction: a post-hoc analysis of T.O.S.C.A. Registry
3 April 2025
thumbnail
Congress Presentation
The efficacy of dual lipid-lowering therapy with ezetimibe and statin on plaque volume regression among patients following percutaneous coronary intervention: a meta-analysis
31 August 2025
thumbnail
Congress Presentation
Effect of 5-lipoxygenase-activating protein inhibiton on coronary atherosclerosis progression in patients with recent acute coronary syndrome: the PASSIVATE randomised clinical trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources